Health plans required to cover the management and treatment of obesity.
HF690 requires Minnesota health plans to cover the diagnosis and treatment of obesity as a chronic disease. The bill specifically requires coverage for intensive health behavior and lifestyle treatment, metabolic and bariatric surgery, and FDA-approved obesity medications. It also defines these terms and allows telehealth, office-based, virtual, and community-based delivery for lifestyle treatment services.
The bill limits how insurers can manage this coverage by prohibiting more restrictive criteria for obesity medications than the FDA-approved indications and by requiring that cost-sharing and benefit design for obesity treatment not be treated differently from coverage for other illnesses. At the same time, it preserves the ability of plans to use utilization management, so long as medical-necessity decisions are made in the same manner as for other covered conditions. The bill applies to health plans issued, offered, or renewed on or after January 1, 2027.
HF690 also amends Minnesota Medical Assistance law to require Medicaid coverage for obesity management and treatment, with the same requirements that apply to private health plans under the new section. That Medicaid provision becomes effective January 1, 2026, or upon federal approval, whichever is later. As a result, the bill would expand coverage obligations for both commercial insurers and the state’s Medical Assistance program.
The available context shows no recorded committee debate or votes, so there is no documented public sentiment in the materials provided. Based on the bill text alone, the measure appears designed to broaden access to evidence-based obesity care and to treat obesity more explicitly as a chronic medical condition within insurance coverage rules.
No specific points of contention are documented in the provided materials, but the bill’s likely pressure points are the required coverage of bariatric surgery and anti-obesity medications, the cost implications for insurers and Medical Assistance, and the limits on how tightly plans may manage or restrict access to treatment. These issues are commonly associated with debates over health care costs, utilization management, and medical necessity standards.
The bill would create a new Minnesota insurance mandate in chapter 62Q requiring health plans to cover obesity diagnosis and treatment, including behavioral/lifestyle treatment, bariatric surgery, and FDA-approved obesity medications, while restricting more burdensome coverage criteria and parity in cost-sharing. It also amends Medical Assistance law in section 256B.0625 to require Medicaid coverage for the same obesity services, subject to federal approval, thereby expanding coverage obligations for both private and public payers.
No committee transcripts or votes were provided, so there is no direct record of support or opposition in the available materials. The bill text suggests a policy goal of expanding access to obesity treatment and recognizing obesity as a chronic disease, which indicates a generally pro-coverage, health-access-oriented posture.
The main likely areas of contention are the cost of mandating coverage for obesity medications and bariatric surgery, the potential premium or budget impact on health plans and Medical Assistance, and the extent to which insurers may use utilization management. Another possible point of debate is whether obesity treatment should be treated like other chronic conditions for deductibles, copays, and medical-necessity review. No specific opponents or supporters are identified in the provided record.